Core Viewpoint - Herbalife Ltd. (NYSE:HLF) is recognized as one of the best-performing affordable stocks under $40, with analysts providing mixed ratings and price targets reflecting differing outlooks on the company's future performance [1][2]. Group 1: Analyst Ratings and Price Targets - Mizuho Securities reiterated a Hold rating on Herbalife, raising the price target from $11 to $13, indicating cautious optimism about the stock's performance [1]. - Maxim Group initiated a Buy rating on Herbalife with a price target of $20, suggesting a more bullish outlook on the company's potential [1]. Group 2: Growth Expectations and Valuation Concerns - Mizuho analysts expect Herbalife to grow and outperform by 2026, but they caution that weak fundamentals and macroeconomic uncertainties are contributing to compressed valuations [2]. - Maxim Group believes a turnaround is underway for Herbalife, which will strengthen its position in the health and wellness sector, citing resolved regulatory concerns and improved distributor relationships [3]. Group 3: Company Overview - Herbalife Ltd. is a leading nutrition company offering health and wellness products across approximately 95 markets globally, including categories such as weight management, targeted nutrition, energy, sports, and fitness products [4].
Here’s What the Wall Street Thinks About Herbalife Ltd. (HLF)